ProMIS Neurosciences, Inc. — Company profile
Healthcare · Biotechnology · Canada
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington’s disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.
Details
| Name | ProMIS Neurosciences, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 11 |
| Founded | 2004 |
| Ceo | Neil Warma |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | CA74346M5054 |
| Cusip | 74346M505 |
| Cik | 1374339 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Neil K. Warma M.B.A. | Chief Executive Officer, President, Compliance Officer and Director |
| Eugene W. Williams | Co-Founder and Chairman |
| Dr. Neil R. Cashman M.D. | Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer and Director |
| Dr. Johanne Kaplan Ph.D. | Chief Development Officer |
| Dr. Larry Douglas Altstiel M.D., Ph.D. | Chief Medical Officer |
| Daniel E. Geffken M.B.A. | Chief Financial Officer |
| Dr. David Wishart Ph.D. | Chief Physics Officer |
| Dennis Chen Ph.D. | Head of Manufacturing and Senior Consultant |
| Dr. Ivana Rubino Ph.D. | Chief Commercial Officer |
Contact
| Address | 1920 Yonge Street, Suite 200, Toronto, ON M4S 3E2, Canada |
| Phone | 416 847 6898 |
| Website | https://www.promisneurosciences.com |